Mark L. Entman
University of Texas Health Science Center at Houston
2 Papers
47 Citations
Mark L. Entman is an academic researcher from University of Texas Health Science Center at Houston. The author has contributed to research in topics: Cell adhesion molecule & STC1. The author has an hindex of 2, co-authored 2 publications.
Chat about Author
Papers
Stanniocalcin-1 is a naturally occurring L-channel inhibitor in cardiomyocytes: relevance to human heart failure.
David Sheikh-Hamad,David Sheikh-Hamad,Roger J. Bick,Gang Yi Wu,Birgitte Mønster Christensen,Peter Razeghi,Brian J. Poindexter,Heinrich Taegtmeyer,Ann Wamsley,Ranjit S. Padda,Mark L. Entman,Søren Nielsen,Keith Youker +12 more
TL;DR: STC1 protein is markedly upregulated in cardiomyocytes and arterial walls of failing hearts pre-LVAD and is strikingly reduced after LVAD treatment, suggesting differential regulation of myocardial STC1protein expression in heart failure.
77
Cardiac Allograft Survival in Mice Deficient in Intercellular Adhesion Molecule–1
Kenneth O. Schowengerdt,Jessica Y. Zhu,Stanislaw M. Stepkowski,Yizheng Tu,Mark L. Entman,Christie M. Ballantyne +5 more
TL;DR: The need to understand more precisely the mechanism of action whereby monoclonal antibodies to ICAM-1 prolong cardiac allograft survival before new therapeutic strategies based on gene transfer technology or small molecule inhibitors are developed is highlighted.
48